TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- As Ontario commits $1.8 billion to expand access to team-based primary care, the Lung Health Foundation (LHF) is calling on the government to take a vital ...

A growing outbreak of Legionnaires’ disease in New York is raising urgent public health concerns as health officials confirm ...

Lung POCUS has become an essential tool in hospital medicine, offering rapid bedside assessment of respiratorypathologies, often outperforming chest radiography.

While the AI system was faster and about as accurate, doctors offered more empathetic and personalised reports in a ...

Primary care physicians are often the first stop for patients with symptoms of shortness of breath. Here’s what to look for.

As frontline partners, PCPs coordinate work-up, referrals, and lifestyle counseling in dyspnea. Review essential steps for ...

Topline data were announced from two phase 3 trials evaluating astegolimab in patients with moderate to very severe COPD.

Roche’s astegolimab met the main goal of one pivotal COPD study but failed another, mirroring the mixed results recently posted by a Regeneron Pharmaceuticals COPD drug candidate that goes after ...

Mohamed Hamdy Yassin, M.D., an infectious disease specialist with University of Pittsburgh Medical Center who sees about 15 to 20 cases of Legionnaires’ disease each year, says ...

Coughing, wheezing and shortness of breath are all familiar respiratory complaints a lot of people think of as signs of ...

Merck has agreed to a $10-billion buyout of Verona Pharma and its first-in-class, potential COPD blockbuster Ohtuvayre.

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma Verona Pharma’s stock soars into record territory after buyout deal with Merck ...